These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9341755)

  • 1. Biologically active, alternatively processed interleukin-1 beta in psoriatic scales.
    Lundqvist EN; Egelrud T
    Eur J Immunol; 1997 Sep; 27(9):2165-71. PubMed ID: 9341755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activity of human epidermal interleukin-1beta: comparison with recombinant human interleukin-1beta.
    Lundqvist EN; Companjen AR; Prens EP; Egelrud T
    Eur Cytokine Netw; 1998 Mar; 9(1):41-6. PubMed ID: 9613676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1 beta activation in human epidermis.
    Nylander-Lundqvist E; Bäck O; Egelrud T
    J Immunol; 1996 Aug; 157(4):1699-704. PubMed ID: 8759758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of interleukin 1 beta from human plantar stratum corneum. Evidence of interleukin 1 beta processing in vivo not involving interleukin 1 beta convertase.
    Brattsand M; Egelrud T
    Cytokine; 1998 Jul; 10(7):506-13. PubMed ID: 9702414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil chemoattractant and IL-1-like activity in samples from psoriatic skin lesions. Further characterization.
    Fincham NJ; Camp RD; Gearing AJ; Bird CR; Cunningham FM
    J Immunol; 1988 Jun; 140(12):4294-9. PubMed ID: 3286771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta.
    Cooper KD; Hammerberg C; Baadsgaard O; Elder JT; Chan LS; Sauder DN; Voorhees JJ; Fisher G
    J Immunol; 1990 Jun; 144(12):4593-603. PubMed ID: 2191038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced production of biologically active interleukin-1 alpha and interleukin-1 beta by psoriatic epidermal cells ex vivo: evidence of increased cytosolic interleukin-1 beta levels and facilitated interleukin-1 release.
    Debets R; Hegmans JP; Troost RJ; Benner R; Prens EP
    Eur J Immunol; 1995 Jun; 25(6):1624-30. PubMed ID: 7614991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
    Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
    J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes.
    Mizutani H; Black R; Kupper TS
    J Clin Invest; 1991 Mar; 87(3):1066-71. PubMed ID: 1999487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated interleukin-18 protein expression in early active and progressive plaque-type psoriatic lesions.
    Companjen A; van der Wel L; van der Fits L; Laman J; Prens E
    Eur Cytokine Netw; 2004; 15(3):210-6. PubMed ID: 15542445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin.
    Bonifati C; Carducci M; Mussi A; D'auria L; Ameglio F
    J Biol Regul Homeost Agents; 1997; 11(4):133-6. PubMed ID: 9582612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
    Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitous interleukin-1 alpha in fetal bovine serum may mislead the experimental results in vitro.
    Hida S; Takeuchi A; Hayashi H; Yano T; Hopkins SJ; Onozaki K
    Eur Cytokine Netw; 1995; 6(2):121-6. PubMed ID: 7578990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriatic skin lesions contain biologically active amounts of an interleukin 1-like compound.
    Camp RD; Fincham NJ; Cunningham FM; Greaves MW; Morris J; Chu A
    J Immunol; 1986 Dec; 137(11):3469-74. PubMed ID: 3491138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment.
    Oxholm A; Oxholm P; Staberg B; Bendtzen K
    Acta Derm Venereol; 1989; 69(3):195-9. PubMed ID: 2566221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-independent expansion of T cells from psoriatic skin lesions: phenotypic characterization and antigen reactivity.
    Horrocks C; Holder JE; Berth-Jones J; Camp RD
    Br J Dermatol; 1997 Sep; 137(3):331-8. PubMed ID: 9349325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.
    Schönbeck U; Mach F; Libby P
    J Immunol; 1998 Oct; 161(7):3340-6. PubMed ID: 9759850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
    Oxholm A
    APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxycycline inhibition of interleukin-1 in the corneal epithelium.
    Solomon A; Rosenblatt M; Li DQ; Liu Z; Monroy D; Ji Z; Lokeshwar BL; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2544-57. PubMed ID: 10937565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha.
    Howard AD; Kostura MJ; Thornberry N; Ding GJ; Limjuco G; Weidner J; Salley JP; Hogquist KA; Chaplin DD; Mumford RA
    J Immunol; 1991 Nov; 147(9):2964-9. PubMed ID: 1919001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.